Letter to the Editor

DOI: 10.1016/j.regg.2023.04.003

Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment”

Respuesta de los autores: «Inmunogenicidad, efectividad y seguridad de la vacuna COVID-19 en adultos mayores que viven hogares geriátricos: comentario»

Visits

37

Download PDF

Héctor Meijide Mígueza, Iñaki Montes Garcíab, Miguel Ochando Gómezc, Isabel M. García Merinod, Emilio L. Canoe,f, Alejandro De La Torreg,

Corresponding author

alejandro.delatorre@imbanaco.com.co

Corresponding author.

a Department of Internal Medicine, Hospital Quironsalud A Coruña, A Coruña, Spain

b Executive Director, Residencia Dulcinea, Grupo Quirónsalud, Alcázar de San Juan, Ciudad. Real, Spain

c Technical Director of Clinical Laboratory, Health Diagnostic, Grupo Quironsalud, Madrid, Spain

d Department of Research and Innovation, Grupo Quirónsalud, Madrid, Spain

e Research Centre for Intelligent Information Technologies (CETINIA-DSLAB), Rey Juan Carlos University, Móstoles, Spain

f Quantitative Methods and Socio-economic Development Group, Institute for Regional Development (IDR), University of Castilla-La Mancha (UCLM), Albacete, Spain

g Scientific Director, Clinica Imbanaco, Grupo Quironsalud, Cali, Valle del Cauca, Colombia